[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate

C24H27F3N6O3 — CID 139969376

IUPAC[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate
SMILESCCc1cc(=O)n(C(C)C)c2nc(Nc3ccc(N4CCNCC4)cc3)nc(OC(=O)C(F)(F)F)c12
InChIInChI=1S/C24H27F3N6O3/c1-4-15-13-18(34)33(14(2)3)20-19(15)21(36-22(35)24(25,26)27)31-23(30-20)29-16-5-7-17(8-6-16)32-11-9-28-10-12-32/h5-8,13-14,28H,4,9-12H2,1-3H3,(H,29,30,31)
InChIKeyUEWYORSZAWYCSE-UHFFFAOYSA-N
MW504.51 g/mol
LogP3.56
Rot. Bonds6

About [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate

[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate (PubChem CID 139969376) has the molecular formula C24H27F3N6O3 and a molecular weight of 504.51 g/mol. Its IUPAC name is [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate.

Molecular Properties

Compound Name[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate
PubChem CID139969376
Molecular FormulaC24H27F3N6O3
Molecular Weight504.51 g/mol
Exact Mass504.21
IUPAC Name[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate
SMILESCCc1cc(=O)n(C(C)C)c2nc(Nc3ccc(N4CCNCC4)cc3)nc(OC(=O)C(F)(F)F)c12
InChIInChI=1S/C24H27F3N6O3/c1-4-15-13-18(34)33(14(2)3)20-19(15)21(36-22(35)24(25,26)27)31-23(30-20)29-16-5-7-17(8-6-16)32-11-9-28-10-12-32/h5-8,13-14,28H,4,9-12H2,1-3H3,(H,29,30,31)
InChIKeyUEWYORSZAWYCSE-UHFFFAOYSA-N
XLogP3.56
TPSA101.38 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500504.51
LogP ≤ 53.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate?
The IUPAC name of [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate (CID 139969376) is [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate.
What is the SMILES notation for [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate?
The canonical SMILES for [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate is CCc1cc(=O)n(C(C)C)c2nc(Nc3ccc(N4CCNCC4)cc3)nc(OC(=O)C(F)(F)F)c12.
What is the InChIKey of [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate?
The InChIKey is UEWYORSZAWYCSE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H27F3N6O3/c1-4-15-13-18(34)33(14(2)3)20-19(15)21(36-22(35)24(25,26)27)31-23(30-20)29-16-5-7-17(8-6-16)32-11-9-28-10-12-32/h5-8,13-14,28H,4,9-12H2,1-3H3,(H,29,30,31).
What are the key properties of [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate?
[5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate has a molecular weight of 504.51 g/mol, XLogP of 3.56, 6 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [5-ethyl-7-oxo-2-(4-piperazin-1-ylanilino)-8-propan-2-ylpyrido[2,3-d]pyrimidin-4-yl] 2,2,2-trifluoroacetate is sourced from PubChem (CID 139969376), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).